Literature DB >> 11523521

Extended-spectrum beta-lactamases: how big is the problem?

J J Rahal1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11523521     DOI： 10.1046/j.1469-0691.2000.00002.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  11 in total

1.  Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.

Authors:  T Spanu; F Luzzaro; M Perilli; G Amicosante; A Toniolo; G Fadda
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals.

Authors:  F Luzzaro; E F Viganò; D Fossati; A Grossi; A Sala; C Sturla; M Saudelli; A Toniolo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 3.267

4.  Mosaic structure of p1658/97, a 125-kilobase plasmid harboring an active amplicon with the extended-spectrum beta-lactamase gene blaSHV-5.

Authors:  M Zienkiewicz; I Kern-Zdanowicz; M Gołebiewski; J Zyliñska; P Mieczkowski; M Gniadkowski; J Bardowski; P Cegłowski
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

5.  Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.

Authors:  C M Lonchel; P Melin; J Gangoué-Piéboji; M-C O Assoumou; R Boreux; P De Mol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-11       Impact factor: 3.267

6.  Two different extended-spectrum beta-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland.

Authors:  Anna Baraniak; Ewa Sadowy; Waleria Hryniewicz; Marek Gniadkowski
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

7.  Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium.

Authors:  Junlong Li; Xiaoli Ji; Xiaohui Deng; Yingfeng Zhou; Xiaoqing Ni; Xiaokang Liu
Journal:  Biomed Rep       Date:  2015-01-07

8.  Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Authors:  K S Thomson; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Characterization of the first extended-spectrum beta-lactamase-producing Salmonella isolate identified in Canada.

Authors:  Michael R Mulvey; Geoff Soule; David Boyd; Walter Demczuk; Rafiq Ahmed
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso.

Authors:  Abdoul-Salam Ouedraogo; Mahamadou Sanou; Aimée Kissou; Soufiane Sanou; Hermann Solaré; Firmin Kaboré; Armel Poda; Salim Aberkane; Nicolas Bouzinbi; Idrissa Sano; Boubacar Nacro; Lassana Sangaré; Christian Carrière; Dominique Decré; Rasmata Ouégraogo; Hélène Jean-Pierre; Sylvain Godreuil
Journal:  BMC Infect Dis       Date:  2016-07-11       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.